recombinant adjuvanted)for the prevention of RSV disease to include adults aged 50-59 at increased risk.Since September 2023, GSK's RSV vaccine has been approved in Japan for
A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or needing intensive care unit support for severe complicati
There's no approved vaccine for RSV, or respiratory syncytial virus, which can be more severe in older adults as well as in very young children. Moderna isn't the only vaccine-maker on the trail of the sought-after vaccine, however: GlaxoSmithKline, Johnson & Johnson and Pfizer all haveva...
The U.S. Food and Drug Administration on Tuesday approvedPfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease. In June, the U.S. CDCnarrowedits recommendation for the use of respiratory ...
1.Du Z, et a.. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Nat Med. 2025 Jan 9. 2.Walsh EE, et al. Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. N Engl J Med. 2023 Apr 20;388(16)...
Pfizer’s ABRYSVO vaccine was safe and generated a strong immune response against respiratory syncytial virus (RSV) in immunocompromised adults aged 18
The vaccines can be co-administered with COVID-19 and influenza vaccines in older adults, and the Abrysvo vaccine can be administered to pregnant women between 24 and 36 weeks gestation. However, the vaccines are not yet available on the National Immunisation Program...
The vaccine, made by the pharmaceutical company GSK, is for older adults. Pfizer and Moderna are also developing similar RSV vaccines. The Centers for Disease Control and Prevention still needs to weigh in with specific recommendations, which is expected in June. GSK anticipates it will have eno...
RSV in Older Adults If you’re an older adult, RSV can be more dangerous. If you’re 75 or older, your doctor may recommend a single dose of the RSV vaccine toprevent problems. Experts also recommend a single dose of the vaccine for adults 60 to 74 years old and up who are at hig...
The US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any mRNA shot has been authorized against a disease other than COVID-19. Ad RSV is a highly contagious seasonal virus that can causesevere symptoms...